Nelson-Miller announces acquisition of KDM

NewsGuard 100/100 Score

Nelson-Miller, Inc., a leading manufacturer of membrane switches and product identification components, announced today that it has acquired KDM from CoActive Technologies.  Nelson-Miller, Inc., based in Los Angeles, designs, manufactures and sources customized membrane switches, graphic overlays, nameplates, rubber keypads, touchscreens and other user-interface and product identification solutions.  The Company's products are highly customized and are used by original equipment manufacturers in a broad range of industries such as healthcare, industrial, aerospace and consumer. 

KDM, with its locations in California, Singapore, and China, is a global provider of user-interface components and modules including keypads, dome arrays and light guides to a premier customer base in the cell phone, point-of-sale, gaming, computing and consumer industries.  This acquisition nearly doubles the revenue of Nelson-Miller, and adds outstanding overseas manufacturing and engineering resources to the business.  The transaction provides immediate reach into new customers, products and end markets and creates a business with market leading domestic and overseas manufacturing resources. 

Nelson-Miller CEO, David Bland, is the former president of KDM, uniquely positioned Nelson-Miller for the acquisition. David comments, "The merger of KDM into Nelson-Miller adds tremendous capacity and resources to our growing business.  KDM is a technology leader in backlighting and interface solutions and has successfully supported industry leaders in the development and manufacturing of innovative products for more than thirty years. We are excited about the potential that this merger brings to the customers of both Nelson-Miller and KDM."  

Source:

Nelson-Miller, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LungVax vaccine uses DNA technology to prevent lung cancer